A LinkedIn post from All G highlights the company’s participation as an exhibitor at the in-cosmetics Global event in Paris. The post emphasizes All G’s focus on precision fermentation to develop a new class of bioactive ingredients, initially centered on its LFX lactoferrin product for skin health applications.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to the post, LFX lactoferrin is positioned to address acne, sebum production, skin inflammation, and skin barrier function, areas typically targeted by premium skincare solutions. The company suggests that its approach may mitigate historical constraints around lactoferrin’s supply, variability, and cost, potentially broadening its use in skincare, oral care, and personal care formulations.
From an investor perspective, the presence at a major cosmetics industry trade show may indicate All G’s intention to build commercial relationships with ingredient buyers and brand owners. If successful, this could translate into partnership opportunities, recurring ingredient revenue, and validation of its precision fermentation platform within the high-margin beauty and personal care market.
The focus on lactoferrin also suggests a strategic positioning in the bioactive protein segment, which has drawn interest for both functional and clean-label claims. While the LinkedIn post does not provide details on pricing, capacity, or regulatory status, broader adoption of LFX by formulators could enhance All G’s competitive standing in biotechnology-enabled cosmetic ingredients and support longer-term scaling of its fermentation infrastructure.